Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Androidâ„¢ device!
Free
Faster access than browser!
 

Fluorine-18 and Radiopharmacology

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Fluorine-18 and Radiopharmacology

Fluorine-18 vs. Radiopharmacology

Fluorine-18 (18F) is a fluorine radioisotope which is an important source of positrons. Radiopharmacology or medicinal radiochemistry is radiochemistry applied to medicine and thus the pharmacology of radiopharmaceuticals (medicinal radiocompounds, that is, pharmaceutical drugs that are radioactive).

Similarities between Fluorine-18 and Radiopharmacology

Fluorine-18 and Radiopharmacology have 3 things in common (in Unionpedia): Cyclotron, Fludeoxyglucose (18F), Radionuclide.

Cyclotron

A cyclotron is a type of particle accelerator invented by Ernest O. Lawrence in 1929-1930 at the University of California, Berkeley, and patented in 1932.

Cyclotron and Fluorine-18 · Cyclotron and Radiopharmacology · See more »

Fludeoxyglucose (18F)

Fludeoxyglucose (18F) (INN), or fludeoxyglucose F 18 (USAN and USP), also commonly called fluorodeoxyglucose and abbreviated FDG, 18F-FDG or FDG, is a radiopharmaceutical used in the medical imaging modality positron emission tomography (PET).

Fludeoxyglucose (18F) and Fluorine-18 · Fludeoxyglucose (18F) and Radiopharmacology · See more »

Radionuclide

A radionuclide (radioactive nuclide, radioisotope or radioactive isotope) is an atom that has excess nuclear energy, making it unstable.

Fluorine-18 and Radionuclide · Radionuclide and Radiopharmacology · See more »

The list above answers the following questions

Fluorine-18 and Radiopharmacology Comparison

Fluorine-18 has 23 relations, while Radiopharmacology has 47. As they have in common 3, the Jaccard index is 4.29% = 3 / (23 + 47).

References

This article shows the relationship between Fluorine-18 and Radiopharmacology. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »